The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

If you have questions about Opdivo for squamous cell lung cancer treatment, talk with your doctor. Is Opdivo approved to treat stage 4 lung cancer? Yes, in certain situations. Stage 4 lung cancer ...

In patients with advanced squamous non–small cell lung cancer, ivonescimab plus chemo was associated with progression-free ...

An experimental Boehringer Ingelheim drug achieved “unprecedented” benefits in patients with an advanced form of lung cancer ...

DelveInsight's "Metastatic Cutaneous Squamous Cell Cancer Market Insights, Epidemiology, and Market Forecast- 2032" report ...

A Post-Treatment Blood Test Could Inform ... have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or ...

The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough device designation by the FDA ...

The global non-small cell lung cancer market is on track for exceptional growth, driven by increasing demand for innovative treatment solutions. According to recent market projections, the market ...

Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very ...

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...